Pages that link to "Q46245134"
Jump to navigation
Jump to search
The following pages link to Lamotrigine as an augmentation agent in treatment-resistant obsessive-compulsive disorder: a case report (Q46245134):
Displaying 17 items.
- The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder (Q24605193) (← links)
- Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment (Q24633004) (← links)
- A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders (Q28082048) (← links)
- Evidence-based pharmacotherapy of obsessive-compulsive disorder (Q34245428) (← links)
- Role of lamotrigine augmentation in treatment-resistant obsessive compulsive disorder: a retrospective case review from South Asia (Q34476167) (← links)
- Topiramate augmentation in a patient with obsessive-compulsive disorder (Q35976177) (← links)
- THE USE OF GLUTAMATE MODULATING DRUGS IN OBSESSIVE COMPULSIVE DISORDER. (Q36647465) (← links)
- Diagnosis and treatment of a patient with both psychotic and obsessive-compulsive symptoms (Q37383381) (← links)
- Management of obsessive-compulsive disorder comorbid with bipolar disorder (Q37400532) (← links)
- Antiepileptic drugs in the treatment of psychiatric disorders (Q37865934) (← links)
- Pharmacotherapy of obsessive-compulsive disorder: evidence-based treatment and beyond (Q38057736) (← links)
- Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study (Q38475793) (← links)
- Glutamate-modulating drugs as a potential therapeutic strategy in obsessive-compulsive disorder. (Q39189451) (← links)
- Lamotrigine augmentation of serotonin reuptake inhibitors in severe and long-term treatment-resistant obsessive-compulsive disorder. (Q41970171) (← links)
- N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial. (Q53162022) (← links)
- Epilepsy and concomitant obsessive-compulsive disorder (Q57139058) (← links)
- Glutamatergic augmentation strategies in obsessive-compulsive disorder (Q61809155) (← links)